Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.

Autor: Hentzien, Maxime1,2 (AUTHOR), Bonnet, Fabrice3,4 (AUTHOR), Bernasconi, Enos5 (AUTHOR), Biver, Emmanuel6 (AUTHOR), Braun, Dominique L.7 (AUTHOR), Munting, Aline8 (AUTHOR), Leuzinger, Karoline9 (AUTHOR), Leleux, Olivier4 (AUTHOR), Musardo, Stefano1 (AUTHOR), Prendki, Virginie10 (AUTHOR), Schmid, Patrick11 (AUTHOR), Staehelin, Cornelia12 (AUTHOR), Stoeckle, Marcel13 (AUTHOR), Walti, Carla S.13 (AUTHOR), Wittkop, Linda3,14,15 (AUTHOR), Appay, Victor16 (AUTHOR), Didierlaurent, Arnaud M.17 (AUTHOR) arnaud.didierlaurent@unige.ch, Calmy, Alexandra1 (AUTHOR) Alexandra.Calmy@hug.ch
Zdroj: BMC Infectious Diseases. 3/19/2024, Vol. 24 Issue 1, p1-9. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje